[go: up one dir, main page]

UA92469C2 - Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile - Google Patents

Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile

Info

Publication number
UA92469C2
UA92469C2 UAA200702178A UAA200702178A UA92469C2 UA 92469 C2 UA92469 C2 UA 92469C2 UA A200702178 A UAA200702178 A UA A200702178A UA A200702178 A UAA200702178 A UA A200702178A UA 92469 C2 UA92469 C2 UA 92469C2
Authority
UA
Ukraine
Prior art keywords
amino
cyanoethenyl
dimethylphenyl
fumarate
pyrimidinyl
Prior art date
Application number
UAA200702178A
Other languages
Russian (ru)
Inventor
Поль Теодоор Агнес Стевенс
Йозеф Пеетерс
Роже Петрус Гереберн Вандекрюйс
Альфред Элизабет Стапперс
Алекс Герман Копманс
Original Assignee
Янссен Фармацевтика Н.В.
Тиботек Фармасьютикелз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MYPI20043578A external-priority patent/MY169670A/en
Application filed by Янссен Фармацевтика Н.В., Тиботек Фармасьютикелз Лтд. filed Critical Янссен Фармацевтика Н.В.
Publication of UA92469C2 publication Critical patent/UA92469C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to the fumarate salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile, pharmaceutical compositions comprising as active ingredient said salt and to processes for their preparation.
UAA200702178A 2004-09-02 2005-09-02 Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile UA92469C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20043578A MY169670A (en) 2003-09-03 2004-09-02 Combinations of a pyrimidine containing nnrti with rt inhibitors

Publications (1)

Publication Number Publication Date
UA92469C2 true UA92469C2 (en) 2010-11-10

Family

ID=38137294

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200702178A UA92469C2 (en) 2004-09-02 2005-09-02 Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile
UAA200701971A UA92467C2 (en) 2004-09-02 2005-09-02 Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200701971A UA92467C2 (en) 2004-09-02 2005-09-02 Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile

Country Status (6)

Country Link
CN (2) CN101056673A (en)
AP (1) AP2296A (en)
CR (1) CR9031A (en)
SG (1) SG155885A1 (en)
UA (2) UA92469C2 (en)
ZA (1) ZA200701826B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103420920B (en) * 2012-05-14 2016-04-27 上海迪赛诺药业有限公司 Rilpivrine hydrochloride alcoholate polymorphic form and preparation method thereof
WO2013170421A1 (en) * 2012-05-14 2013-11-21 上海迪赛诺药业有限公司 Rilpivirine hydrochloride alcoholate polymorph and preparation method thereof
CA3039562A1 (en) * 2016-10-24 2018-05-03 Janssen Sciences Ireland Unlimited Company Dispersible compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (en) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv Hiv inhibiting pyrimidines derivatives
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
CN101481356B (en) * 2002-08-09 2012-07-11 詹森药业有限公司 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

Also Published As

Publication number Publication date
AP2296A (en) 2011-10-31
ZA200701826B (en) 2008-07-30
SG155885A1 (en) 2009-10-29
UA92467C2 (en) 2010-11-10
CR9031A (en) 2009-01-16
CN101068597B (en) 2012-04-18
AP2007003934A0 (en) 2007-04-30
CN101068597A (en) 2007-11-07
CN101056673A (en) 2007-10-17

Similar Documents

Publication Publication Date Title
FR16C1025I1 (en) 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile salt
JO2973B1 (en) Fumarate Salt Of (alphaS, betaR)-6-Bromo-alfa-[2-(dimethylamino)ethyl]-2- Methoxy-alpha-1-naphthalenyl-beta-phenyl-3- Quinolineethanol
MX338920B (en) Method for the production of amino crotonyl compounds.
PL373679A1 (en) Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2009007441A3 (en) Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
MY122707A (en) Pharmaceutical compositions
SG193245A1 (en) Crystalline and non- crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
WO2007042786A3 (en) 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors
ATE541573T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LAPATINIB
PL1632232T6 (en) Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
IL181649A0 (en) Furamate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino) benzonitrile
UA92469C2 (en) Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile
HRP20110563T1 (en) Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
AP2487A (en) Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile